![Jonathan Rigby](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jonathan Rigby
Directeur Général chez
SERNOVA BIOTHERAPEUTICS INC
Fortune : 69 264 $ au 31/05/2026
Profil
Mr. Jonathan M.
Rigby is a Chief Executive Officer at Sernova Biotherapeutics, Inc., a Chairman & Chief Business Officer at BioPlus Acquisition Corp.
and a Chairman at Association of Needle-Free Injection Manufacturers.
He is on the Board of Directors at Oncolytics Biotech, Inc., Aurimi Therapeutics, Inc., Exciting Instruments Ltd., ReAlta Life Sciences, Inc. and Thermalin, Inc. Mr. Rigby was previously employed as a President, Group CEO & Director by Revolo Biotherapeutics Ltd., a Chairman by CollPlant Biotechnologies Ltd., an Independent Non-Executive Director by Xeris Pharmaceuticals, Inc., a President, Chief Executive Officer & Director by SteadyMed Ltd., a President, Chief Executive Officer & Director by SteadyMed Therapeutics, Inc., a Vice President-Business Development by Zogenix, Inc., a Vice President-Business Development by Aradigm Corp., a Head-Business Development & Sales by Profile Therapeutics Plc, and a Principal by Merck & Co., Inc. He received his undergraduate degree from The University of Sheffield and an MBA from the University of Portsmouth.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ONCOLYTICS BIOTECH INC. 0,04 % | 01/06/2026 | 42 728 ( 0,04 % ) | 44 437 $ | 31/05/2026 |
| 14/04/2026 | 229 877 ( 0,07 % ) | 24 827 $ | 31/05/2026 |
Postes actifs de Jonathan Rigby
| Sociétés | Poste | Début |
|---|---|---|
| BIOPLUS ACQUISITION CORP. | Président | 01/07/2021 |
| ONCOLYTICS BIOTECH INC. | Directeur/Membre du Conseil | 30/08/2022 |
| SERNOVA BIOTHERAPEUTICS INC | Directeur Général | 12/08/2024 |
Thermalin, Inc.
 Thermalin, Inc. Pharmaceuticals: MajorHealth Technology Develops insulin treatments for patients with diabetes | Directeur/Membre du Conseil | - |
ImmunoMolecular Therapeutics, Inc.
 ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno-therapeutic drugs for autoimmune diseases | Directeur/Membre du Conseil | 27/01/2021 |
Association of Needle-Free Injection Manufacturers | Président | 07/09/2010 |
ReAlta Life Sciences, Inc.
 ReAlta Life Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops novel class of drugs with dual-targeting therapeutic capabilities | Directeur/Membre du Conseil | - |
Anciens postes connus de Jonathan Rigby
| Sociétés | Poste | Fin |
|---|---|---|
Revolo Biotherapeutics Ltd.
 Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops immunologic and inflammatory medications | Directeur Général | 22/02/2024 |
| STEADYMED LTD | Directeur Général | 01/01/2020 |
| ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Jonathan Rigby
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
50
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Aradigm Corp.
 Aradigm Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes products for the treatment and prevention of respiratory diseases | Health Technology |
Oncolytics Biotech, Inc.
 Oncolytics Biotech, Inc. BiotechnologyHealth Technology Discovers and develops pharmaceutical products for the treatment of cancers | Health Technology |
Sernova Biotherapeutics, Inc.
 Sernova Biotherapeutics, Inc. BiotechnologyHealth Technology Develops life science products | Health Technology |
Xeris Pharmaceuticals, Inc.
 Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ready-to-use and liquid-stable injectables | Health Technology |
Zogenix, Inc.
 Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets medicines | Health Technology |
Respironics Ltd.
 Respironics Ltd. Financial ConglomeratesFinance Develops and manufactures medical and healthcare products | Finance |
The University of Sheffield
 The University of Sheffield Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Portsmouth
 University of Portsmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Association of Needle-Free Injection Manufacturers | |
SteadyMed Therapeutics, Inc.
 SteadyMed Therapeutics, Inc. Medical/Nursing ServicesHealth Services Develops drug delivery therapeutics devices | Health Services |
Thermalin, Inc.
Thermalin, Inc. Pharmaceuticals: MajorHealth Technology Develops insulin treatments for patients with diabetes | Health Technology |
CollPlant Biotechnologies Ltd.
 CollPlant Biotechnologies Ltd. Medical SpecialtiesHealth Technology Develops and commercializes medical devices | Health Technology |
SteadyMed Ltd.
 SteadyMed Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, and manufacture of pharmaceutical products | Health Technology |
ImmunoMolecular Therapeutics, Inc.
ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno-therapeutic drugs for autoimmune diseases | Health Technology |
Revolo Biotherapeutics Ltd.
Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops immunologic and inflammatory medications | Health Technology |
ReAlta Life Sciences, Inc.
ReAlta Life Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops novel class of drugs with dual-targeting therapeutic capabilities | Health Technology |
BioPlus Acquisition Corp.
 BioPlus Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
